Two stocks in Medical Instruments & Supplies
Alcon vs Ypsomed Holding: profit, growth, debt and price compared
Alcon and Ypsomed Holding are each stronger on 3 of 7 figures: Alcon on sales growth, debt and price for its expected profit; Ypsomed Holding on profit margin, dividend and price trend.
Save both stocks to your watchlist and revisit their latest fundamentals.
| AlconALC.SW | Ypsomed HoldingYPSN.SW | |
|---|---|---|
| Net margin | 6.1% | Stronger: 30.4% |
| Revenue growth, past year | Stronger: +4.70% | −13.30% |
| Debt to equity | Stronger: 24.6% | 34.9% |
| Forward P/E | Stronger: 17.3× | 28.8× |
| Dividend yield | 0.45% | Stronger: 1.04% |
| Analysts | Buy · 17 | Buy · 14 |
| From its 200-day average | +7.2% | Stronger: +21.2% |
Share price over the past year
- Alcon+1.5%
- Ypsomed Holding+34.1%
17 Nov 202518 Nov 2026
Alcon or Ypsomed Holding: which is stronger?
- YPSN.SW
Which is more profitable?
Ypsomed Holding keeps more of each sale as profit: 30.4% against 6.1%.
- ALC.SW
Which is growing its sales faster?
Alcon is growing its sales faster: +4.70% over the past year, against −13.30%.
- ALC.SW
Which has borrowed less?
Alcon has borrowed less: its debt is 24.6% of what its shareholders own, against 34.9% for Ypsomed Holding.
- ALC.SW
Which costs less for the profit it is expected to make?
Alcon costs less for the profit it is expected to make: 17.3× its forward earnings, against 28.8×.
- YPSN.SW
Which pays more in dividends?
Ypsomed Holding pays more back in dividends for what a share costs: 1.04% a year, against 0.45%.
Which do analysts rate higher?
Analysts rate both the same: Buy.
- YPSN.SW
Which is in the stronger price trend?
Ypsomed Holding's price is in the stronger trend: 21.2% above its 200-day average, against 7.2% above.
What each company does
ALC.SWAlcon
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide.
Reports results on 23 February 2027
YPSN.SWYpsomed Holding
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally.
Reports results on 19 May 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.